Bausch Health Companies (BHC) Retained Earnings (2009 - 2026)
Bausch Health Companies' (BHC) quarterly Retained Earnings came in at -$10.8 billion in Q2 2026, down 11.28% year-over-year from -$12.2 billion in Q2 2025, and up 2.33% quarter-over-quarter from -$11.1 billion in Q1 2026.
Analysis
Bausch Health Companies (BHC) Retained Earnings (2009 - 2026) Analysis & Trends
Bausch Health Companies has disclosed Retained Earnings across 18 years of filings, most recently posting -$10.8 billion for Q2 2026.
- In Q2 2026, Retained Earnings fell 11.28% year-over-year to -$10.8 billion; the TTM figure through Jun 2026 stood at -$10.8 billion (down 11.28% YoY), while the FY2025 annual figure was -$9.7 billion, up 1.6% from the prior year.
- Retained Earnings came in at -$10.8 billion for Q2 2026 at Bausch Health Companies, up from -$11.1 billion in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of -$8.8 billion in Q3 2022 to a low of -$11.1 billion in Q1 2026.
- Average Retained Earnings over 5 years is -$9.7 billion, with a median of -$9.7 billion recorded in 2023.
- Year-over-year, Retained Earnings grew 3.65% in 2025 and slipped 12.22% in 2026.
- Over 5 years, Retained Earnings stood at -$9.2 billion in 2022, then decreased by 6.44% to -$9.8 billion in 2023, then fell by 0.47% to -$9.8 billion in 2024, then advanced by 1.6% to -$9.7 billion in 2025, then dropped by 12.05% to -$10.8 billion in 2026.
- Per Business Quant data, the three most recent Retained Earnings figures were -$10.8 billion in Q2 2026, -$11.1 billion in Q1 2026, and -$9.7 billion in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.33 Bn | 38.68 Bn | 2.15 Bn | 28.26 Bn |
| 2 | Viatris | 19.05 Bn | 18.16 Bn | 1.46 Bn | 18.56 Bn |
| 3 | Dr Reddys Laboratories | 9.76 Bn | 9.58 Bn | 396.53 Mn | 3.76 Bn |
| 4 | Amneal Pharmaceuticals | 5.38 Bn | 5.25 Bn | 334.51 Mn | 545.58 Mn |
| 5 | Bausch Health Companies | 2.27 Bn | 436.38 Mn | 2.10 Bn | -10.83 Bn |
| 6 | Alvotech | 1.51 Bn | 1.37 Bn | 2.56 Mn | -2.48 Bn |
| 7 | Ani Pharmaceuticals | 1.51 Bn | 1.15 Bn | 165.89 Mn | 620.25 Mn |
| 8 | Amphastar Pharmaceuticals | 1.03 Bn | 737.26 Mn | 93.47 Mn | 703.65 Mn |
| 9 | Fennec Pharmaceuticals | 393.12 Mn | 351.87 Mn | 17.15 Mn | -227.25 Mn |
| 10 | RedHill Biopharma | 171.02 Mn | 171.02 Mn | - | -413.76 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -10.83 Bn |
| Mar 31, 2026 | -11.09 Bn |
| Dec 31, 2025 | -9.67 Bn |
| Sep 30, 2025 | -9.56 Bn |
| Jun 30, 2025 | -9.73 Bn |
| Mar 31, 2025 | -9.88 Bn |
| Dec 31, 2024 | -9.82 Bn |
| Sep 30, 2024 | -9.92 Bn |
| Jun 30, 2024 | -9.83 Bn |
| Mar 31, 2024 | -9.84 Bn |
| Dec 31, 2023 | -9.78 Bn |
| Sep 30, 2023 | -9.74 Bn |
| Jun 30, 2023 | -9.36 Bn |
| Mar 31, 2023 | -9.39 Bn |
| Dec 31, 2022 | -9.19 Bn |
| Sep 30, 2022 | -8.78 Bn |
| Jun 30, 2022 | -9.18 Bn |
| Mar 31, 2022 | -9.03 Bn |
| Dec 31, 2021 | -8.96 Bn |
| Sep 30, 2021 | -9.03 Bn |